Current overview of statin-induced myopathy

This publication has 82 references indexed in Scilit:

• Physicians’ interpretation of “class effects”
  Journal of the American College of Cardiology, 2002
• Effects of HMG-CoA Reductase Inhibitors on Skeletal Muscle
  Drug Safety, 2002
• Lack of a Clinically Significant Pharmacokinetic Interaction between Fenofibrate and Pravastatin in Healthy Volunteers
  The Journal of Clinical Pharmacology, 2000
• Long-Term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia
  Clinical Cardiology, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
  Clinical Pharmacokinetics, 1998
• The effect of Simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle
  The American Journal of Cardiology, 1996
• Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.
  Journal of Clinical Pathology, 1993
• Efficacy and long-term adverse effect pattern of lovastatin
  The American Journal of Cardiology, 1988
• Adverse Effects of Drugs on Muscle
  Drugs, 1982